L Rybicki
Overview
Explore the profile of L Rybicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehdi A, Rybicki L, Mossad S, Yurch M, Sekeres M, Gerds A, et al.
Bone Marrow Transplant
. 2017 Sep;
52(12):1665-1667.
PMID: 28869614
No abstract available.
2.
Nazha A, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds A, et al.
Bone Marrow Transplant
. 2016 Oct;
51(12):1642-1643.
PMID: 27721371
No abstract available.
3.
Hong S, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds A, et al.
Bone Marrow Transplant
. 2016 Apr;
51(9):1191-6.
PMID: 27111046
Socioeconomic status (SES) is an important determinant of disparities in health care. The association of SES with outcomes in autologous hematopoietic cell transplantation (AHCT) has not been described previously. We...
4.
Mani S, Rybicki L, Jagadeesh D, Mossad S
Bone Marrow Transplant
. 2016 Jan;
51(5):713-7.
PMID: 26726944
Clostridium difficile infection (CDI) is one of the leading causes of hospital-acquired infections in recent times. Hematopoietic stem cell transplantation (HSCT) confers increased risk for CDI because of prolonged hospital...
5.
Hong S, Valent J, Rybicki L, Abounader D, Bolwell B, Dean R, et al.
Bone Marrow Transplant
. 2016 Jan;
51(5):732-4.
PMID: 26726941
No abstract available.
6.
Hamilton B, Rybicki L, Haddad H, Abounader D, Yurch M, Majhail N, et al.
Blood Cancer J
. 2015 Aug;
5:e344.
PMID: 26314986
No abstract available.
7.
Fu S, Rybicki L, Abounader D, Andresen S, Bolwell B, Dean R, et al.
Bone Marrow Transplant
. 2015 Jul;
50(10):1326-30.
PMID: 26191953
The relationship of socioeconomic status (SES) with long-term outcomes in allogeneic hematopoietic cell transplantation (HCT) survivors has not been well described. We studied the association of SES with the outcomes...
8.
Hamilton B, Law A, Rybicki L, Abounader D, Dabney J, Dean R, et al.
Bone Marrow Transplant
. 2015 Jun;
50(9):1235-40.
PMID: 26030045
Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to patient and disease related risk factors has not been...
9.
Hamilton B, Rybicki L, Sekeres M, Kalaycio M, Hanna R, Sobecks R, et al.
Bone Marrow Transplant
. 2015 Mar;
50(6):834-9.
PMID: 25798671
The impact of race on outcome has been identified in a number of cancers, with African Americans having poorer survival compared with whites. We conducted a study to investigate the...
10.
Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, et al.
Bone Marrow Transplant
. 2014 Aug;
49(10):1310-6.
PMID: 25111516
Vancomycin-resistant enterococcus (VRE) is a well-known infectious complication among immunocompromised patients. We performed a retrospective analysis to identify risk factors for the development of VRE bacteremia (VRE-B) within 15 months...